NASDAQ:INOV - Inovalon Stock Price, News & Analysis

$17.34
-0.16 (-0.91 %)
(As of 09/15/2019 06:50 AM ET)
Today's Range
$17.34
Now: $17.34
$17.6450
50-Day Range
$14.91
MA: $16.23
$17.50
52-Week Range
$9.19
Now: $17.34
$17.80
Volume487,738 shs
Average Volume561,948 shs
Market Capitalization$2.67 billion
P/E Ratio60.35
Dividend YieldN/A
Beta0.59
Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering data-driven healthcare. It operates the Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. Read More…

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:INOV
CUSIPN/A
Phone301-809-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$527.68 million
Cash Flow$0.8222 per share
Book Value$4.47 per share

Profitability

Net Income$-39,160,000.00

Miscellaneous

Employees2,499
Market Cap$2.67 billion
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.


Inovalon (NASDAQ:INOV) Frequently Asked Questions

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon's earnings last quarter?

Inovalon Holdings Inc (NASDAQ:INOV) posted its earnings results on Wednesday, July, 31st. The technology company reported $0.11 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.08 by $0.03. The technology company earned $156.98 million during the quarter, compared to analyst estimates of $155.72 million. Inovalon had a negative net margin of 2.70% and a positive return on equity of 6.39%. Inovalon's revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.13 earnings per share. View Inovalon's Earnings History.

When is Inovalon's next earnings date?

Inovalon is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Inovalon.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon updated its FY19 earnings guidance on Wednesday, July, 31st. The company provided earnings per share (EPS) guidance of $0.45-0.49 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.45. The company issued revenue guidance of $638-648 million, compared to the consensus revenue estimate of $639.44 million.

What price target have analysts set for INOV?

3 equities research analysts have issued 1 year target prices for Inovalon's shares. Their predictions range from $11.00 to $22.00. On average, they anticipate Inovalon's share price to reach $17.00 in the next twelve months. This suggests that the stock has a possible downside of 2.0%. View Analyst Price Targets for Inovalon.

What is the consensus analysts' recommendation for Inovalon?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inovalon.

Has Inovalon been receiving favorable news coverage?

News stories about INOV stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Inovalon earned a daily sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Inovalon.

Who are some of Inovalon's key competitors?

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Alibaba Group (BABA), ConforMIS (CFMS), OncoSec Medical (ONCS), Opko Health (OPK), Ford Motor (F), General Electric (GE), AcelRx Pharmaceuticals (ACRX), Amarin (AMRN), Corcept Therapeutics (CORT) and Corbus Pharmaceuticals (CRBP).

Who are Inovalon's key executives?

Inovalon's management team includes the folowing people:
  • Keith R. Dunleavy, CEO & Chairman (Age 50)
  • Mr. Robert A. Wychulis, Pres (Age 64)
  • Mr. John Michael Burgin, Chief Product Officer (Age 45)
  • Mr. Jonathan R. Boldt, Chief Financial Officer (Age 34)
  • Mr. Jason B. Capitel, Chief Operating Officer (Age 47)

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Who are Inovalon's major shareholders?

Inovalon's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (4.18%), BlackRock Inc. (3.24%), Bernzott Capital Advisors (0.92%), Northern Trust Corp (0.64%), Riverbridge Partners LLC (0.51%) and Cowen Prime Services LLC (0.48%). Company insiders that own Inovalon stock include Jason Capitel, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis and Shauna L Vernal. View Institutional Ownership Trends for Inovalon.

Which institutional investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Parametric Portfolio Associates LLC, Citadel Advisors LLC, HarbourVest Partners LLC, Harbourvest Partners LLC, BlackRock Inc., Riverbridge Partners LLC, Morgan Stanley and SG Americas Securities LLC. View Insider Buying and Selling for Inovalon.

Which institutional investors are buying Inovalon stock?

INOV stock was acquired by a variety of institutional investors in the last quarter, including Bernzott Capital Advisors, Nuveen Asset Management LLC, First Trust Advisors LP, Cowen Prime Services LLC, Isthmus Partners LLC, Vanguard Group Inc., Bank of America Corp DE and Sawgrass Asset Management LLC. Company insiders that have bought Inovalon stock in the last two years include Jason Capitel, Keith R Dunleavy and Lee D Roberts. View Insider Buying and Selling for Inovalon.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $17.34.

How big of a company is Inovalon?

Inovalon has a market capitalization of $2.67 billion and generates $527.68 million in revenue each year. The technology company earns $-39,160,000.00 in net income (profit) each year or $0.18 on an earnings per share basis. Inovalon employs 2,499 workers across the globe.View Additional Information About Inovalon.

What is Inovalon's official website?

The official website for Inovalon is http://www.inovalon.com/.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]


MarketBeat Community Rating for Inovalon (NASDAQ INOV)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  271 (Vote Outperform)
Underperform Votes:  331 (Vote Underperform)
Total Votes:  602
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel